KLUS PHARMA

Founded in 2014 as a subsidiary of Kelun-Biotech, KLUS Pharma is committed to fostering global collaboration and maximizing the value of our diverse pipeline. Our top priority is addressing the unmet needs of patients suffering from cancer, cardiovascular disease, autoimmune disease, and other severe diseases due to the lack of effective treatment options. Utilizing our innovative technology platforms for small molecules, antibodies, and Antibody-Drug Conjugates (ADCs), we have advanced multiple candidates into clinical trials to treat these debilitating conditions... KLUS Pharma is based in Cranbury, NJ, and is the wholly-owned U.S. subsidiary of Kelun-Biotech, a corporation based in Chengdu, China... KLUS Pharma is the US subsidiary of Kelun-Biotech, a China-based corporation with a broad pipeline targeting unmet needs in oncology and other serious diseases.

Also known as: KLUS Pharma Inc.

Primary location: Princeton United States